Business
‘Trust someone’: AstraZeneca boss says transparency key for vaccine – Sydney Morning Herald
The boss of global biotech firm AstraZeneca has confirmed the company is still waiting for its US trial to restart.
The pause of the trial prompted global calls for more transparency on how COVID-19 vaccines are developed.
Mr Soriot, who is also a director of CSL, said he understood the desire for that transparency but that the integrity of trials also had to be protected. “We are looking at how much transparency we can provide, considering we are in a very special set of circumstances,” he said.
Johnson & Johnson’s chief scientific officer Dr Paul Stoffels.
AstraZeneca was working with other vaccine m…
Continue Reading
